Glaukos (GKOS) Share-based Compensation Growth (3y) (2017 - 2026)
Glaukos (GKOS) Share-based Compensation Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 8.37% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | -28.31% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 13.19% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 4.11% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | -0.59% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 17.13% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 36.49% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 3.40% |
| 10 | Glaukos | 11.08 Bn | 10.96 Bn | 151.59 Mn | 460.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 460.34% |
| Mar 31, 2026 | 131.17% |
| Dec 31, 2025 | 13.96% |
| Sep 30, 2025 | 114.05% |
| Jun 30, 2025 | 323.04% |
| Mar 31, 2025 | 13.21% |
| Dec 31, 2024 | 40.07% |
| Sep 30, 2024 | 32.57% |
| Jun 30, 2024 | 24.91% |
| Mar 31, 2024 | -7.77% |
| Dec 31, 2023 | 14.09% |
| Sep 30, 2023 | 2.77% |
| Jun 30, 2023 | -34.44% |
| Mar 31, 2023 | -32.45% |
| Dec 31, 2022 | -9.13% |
| Sep 30, 2022 | 3.26% |
| Jun 30, 2022 | -9.30% |
| Mar 31, 2022 | -34.56% |
| Dec 31, 2021 | 2.71% |
| Sep 30, 2021 | -23.69% |